MedPath
NMPA Approval

Iptacopan Hydrochloride Capsules

国药准字HJ20240016

April 24, 2024

Drug Information

盐酸伊普可泮胶囊

飞赫达

胶囊剂

200mg (按C₂₅H₃₀N₂O₄计)

化学药品

April 24, 2024

April 23, 2029

Company Information

Applicant Company

6343 Risch, Switzerland

Manufacturing Company

Oeflinger Str. 44, 79664 Wehr, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸伊普可泮胶囊 - NMPA 批准文号 | MedPath